Artelo Biosciences gets second 180-day Nasdaq extension to meet $1 minimum bid price

ARTELO BIOSCIENCES, INC.

Nasdaq granted second 180-day period until September 12, 2022 to regain compliance with bid price rule.
Failure to comply by deadline will result in delisting notice; company may appeal to hearings panel.
Company plans to monitor closing bid price and consider available options to regain compliance.
Stock trades under ticker ARTL on Nasdaq; minimum bid price requirement is $1.00.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.